» Articles » PMID: 19362258

Independent Emergence of Colistin-resistant Acinetobacter Spp. Isolates from Korea

Overview
Date 2009 Apr 14
PMID 19362258
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

High colistin resistance rates in Acinetobacter spp. were recently reported in Korean hospitals (J. Antimicrob. Chemother 2007;60:1163). In this study, we investigated if colistin-resistant Acinetobacter spp. isolates from Korean hospitals disseminated clonally or emerged independently. Multilocus sequence typing (MLST) analysis was performed for 58 colistin-resistant Acinetobacter spp. isolates: 8 isolates of the Acinetobacter baumannii subgroup A, 16 isolates of the A. baumannii subgroup B, and 34 isolates of the genomic species 13TU. A phylogenetic tree inferred from concatenated sequences of 7 MLST loci showed a clear distinction among the 3 Acinetobacter groups. In the MLST analysis, most colistin-resistant Acinetobacter spp. isolates showed different allele profiles at the 7 loci; that is, they belonged to different clones. Despite the clear distinction between the 3 Acinetobacter groups, interrelationships among the 3 groups were not consistent within the gene trees. In addition, some isolates showed clustering incongruent with their species or group identities in some gene trees. MLST analysis indicated that most colistin-resistant Acinetobacter spp. isolates from Korean hospitals arose independently. Considering the increasing use of colistin and the high recombination rate of Acinetobacter spp., independent but frequent emergence of colistin resistance in Acinetobacter spp. isolates is of great concern.

Citing Articles

Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.

Kamoshida G, Yamada N, Nakamura T, Yamaguchi D, Kai D, Yamashita M Microbiol Spectr. 2022; 10(5):e0192822.

PMID: 36173297 PMC: 9602988. DOI: 10.1128/spectrum.01928-22.


Identification of Two Variants of Acinetobacter baumannii Strain ATCC 17978 with Distinct Genotypes and Phenotypes.

Wijers C, Pham L, Menon S, Boyd K, Noel H, Skaar E Infect Immun. 2021; 89(12):e0045421.

PMID: 34460288 PMC: 8594612. DOI: 10.1128/IAI.00454-21.


Colistin resistance in Enterobacter spp. isolates in Korea.

Hong Y, Lee J, Ko K J Microbiol. 2018; 56(6):435-440.

PMID: 29858832 DOI: 10.1007/s12275-018-7449-0.


The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.

Uppuluri P, Lin L, Alqarihi A, Luo G, Youssef E, Alkhazraji S PLoS Pathog. 2018; 14(5):e1007056.

PMID: 29746596 PMC: 5963808. DOI: 10.1371/journal.ppat.1007056.


Growth Rate and Biofilm Formation Ability of Clinical and Laboratory-Evolved Colistin-Resistant Strains of .

Farshadzadeh Z, Taheri B, Rahimi S, Shoja S, Pourhajibagher M, Haghighi M Front Microbiol. 2018; 9:153.

PMID: 29483899 PMC: 5816052. DOI: 10.3389/fmicb.2018.00153.